Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY
Aug 11, 2023 · At a consolidated level, revenues rose 59 per cent YoY to Rs 3,516 crore driven primarily by the 106 per cent jump in biosimilars revenue. Research services revenue rose 25 …
OFF
Biocon Registers Rs 3,516 Crore Revenues In Q1, Up 59% YoY
2 weeks from now
Aug 11, 2023 · At a consolidated level, revenues rose 59 per cent YoY to Rs 3,516 crore driven primarily by the 106 per cent jump in biosimilars revenue. Research services revenue rose 25 …
thestatesman.com
OFF
Press Releases - Biocon Biologics - Global Biopharmaceutical …
2 weeks from now
Jan 30, 2025 · Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% . Aug 10, 2023 . Biocon Biologics Announces Key Leadership …
bioconbiologics.com
OFF
Biocon Registers Rs 3,516 Crore Revenues In Q1, Up 59% YoY - DT …
2 weeks from now
Aug 11, 2023 · At a consolidated level, revenues rose 59 per cent YoY to Rs 3,516 crore driven primarily by the 106 per cent jump in biosimilars revenue. Research services revenue rose 25 …
dtnext.in
OFF
Biocon Q1 Profit Drops 29.8% To Rs 101.40 Crore, Revenue Up 60
2 weeks from now
Aug 11, 2023 · Biocon posted revenue from operations at Rs 3422.60 crore, up 60 per cent as against Rs 2139.50 crore. ... revenues rose 59 per cent YoY to Rs 3516 crore driven primarily …
financialexpress.com
OFF
Biocon Q1FY25 Revenue Up 30% At Rs 4,567 Cr EBITDA Up 117
2 weeks from now
Aug 8, 2024 · Financial Commentary: Q1FY25 . Total Consolidated Revenue for Q1FY25 grew 30% year-on-year (YoY) to Rs 4,567 crore.. Other Income includes proceeds of Rs 1,057 …
biocon.com
OFF
Biocon Buys Back An Investor Stake In Biologics Unit, Posts Rs 25 …
2 weeks from now
Jan 30, 2025 · Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected to complete by February 1, …
indiatimes.com
OFF
Biocon Q1FY21 Revenue At Rs 1,690 Cr, Up 14%; - PressRoom
2 weeks from now
Jul 23, 2020 · Biocon Q1FY21 Revenue at Rs 1,690 Cr, Up 14%; EBITDA at Rs 432 Cr; Net Profit (from continuing ops) at Rs 153 Cr Generics up 16% at Rs 599 Cr, Biosimilars up 19% at Rs …
biocon.com
OFF
Biocon Q1FY25 Revenue Up 30% At Rs 4,567 Cr EBITDA Up …
2 weeks from now
EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr Bengaluru, Karnataka, India: August 8, 2024: Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global …
biocon.com
OFF
Biocon Q4FY23 Revenue At Rs 3,929 Cr, Up 59%;
2 weeks from now
May 23, 2023 · Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% EBITDA at Rs 1,152 Cr, Up 75%; Net Profit (before exceptional …
biocon.com
OFF
Biocon Q1FY23 Revenue At Rs 2,217 Cr, Up 23%; Net Profit At Rs …
2 weeks from now
Jul 27, 2022 · BIOCON GROUP “We have had a strong start to the year. At a consolidated level, y-o-y revenues grew 23% backed by robust growth in both Biosimilars (29%) and Generics …
bioconbiologics.com
OFF
Biocon Q1FY21 Revenue At Rs 1,690 Cr, Up 14%; EBITDA At Rs …
2 weeks from now
Biocon Park, Bengaluru received the EIR (Establishment Inspection Report) with a VAI (Voluntary Action Indicated) status from the U.S. FDA in May for the pre-approval and GMP inspection …
biocon.com
OFF
Biocon Q4FY22 Revenue At Rs 2,476 Cr, Up 21%; Core EBITDA At …
2 weeks from now
Apr 28, 2022 · FY22 Revenue at Rs 8,397 Cr, Up 14%; Core EBITDA Up 18% at Rs 2,669 Cr; PBT (before Exceptional Item) at Rs 1094 Cr, Up 4% Bengaluru, Karnataka, India: April 28, …
bioconbiologics.com
OFF
Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%# EBITDA At Rs 787 …
2 weeks from now
Jan 30, 2025 · Financial Commentary: Q3FY25. Consolidated Total Revenue for Q3FY25 was at Rs 3,856 crore.Reported 7% YoY growth on a like-for-like basis, after adjusting for Branded …
biocon.com
OFF
Biocon Q3FY22 Revenue At Rs 2,223 Cr, Up 18%; EBITDA At Rs 537 …
2 weeks from now
Jan 20, 2022 · Commenting on the results, Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, said, “Biocon’s consolidated Q3FY22 revenues grew by 18% YoY to Rs 2,223 Crore, …
bioconbiologics.com
OFF
Biocon Q4FY21 Revenue At Rs 2,044 Cr, Up 26%; EBITDA At Rs 641 …
2 weeks from now
FY21 Revenue Up 14% at Rs 7,360 Cr; EBITDA Up 8% at Rs 1,907 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 754 Cr. Bengaluru, Karnataka, India: April …
biocon.com
OFF
Biocon Q1FY22 Revenue At Rs 1,808 Cr, Up 6%; EBITDA At Rs 437 …
2 weeks from now
Jul 23, 2021 · Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr; ... Q1FY22 Net …
biocon.com
OFF
Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …
2 weeks from now
Mar 9, 2023 · EBITDA at Rs 723 Cr, Up 35%; Core EBITDA at Rs 1,069 Cr, Up 49%; Net Profit (excluding exceptional items) at Rs 140 Cr Bengaluru, Karnataka, India: February 14, 2023: …
bioconbiologics.com
FAQs about Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY Coupon?
How did Biocon perform in q1fy25?
How did Biocon perform in fiscal first quarter?
How did Biocon biologics & Eris Lifesciences perform in q1fy25?
How will Biocon's R&D investments drive its future growth?
Why did Biocon grow 10 per cent sequential revenue?
Does Biocon have any obligation to update a forward-looking statement?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
